Targeting non-apoptotic cell death in cancer treatment by nanomaterials: Recent advances and future outlook
Date
2020
Authors
Sepand, M.R.
Ranjbar, S.
Kempson, I.M.
Akbariani, M.
Muganda, W.C.A.
Müller, M.
Ghahremani, M.H.
Raoufi, M.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Nanomedicine: Nanotechnology, Biology, and Medicine, 2020; 29(102243)
Statement of Responsibility
Conference Name
Abstract
Many tumors develop resistance to most of the apoptosis-based cancer therapies. In this sense targeting non-apoptotic forms of cell death including necroptosis, autophagy and ferroptosis may have therapeutic benefits in apoptosis-defective cancer cells. Nanomaterials have shown great advantages in cancer treatment owing to their unique characteristics. Besides, the capability of nanomaterials to induce different forms of cell death has gained widespread attention in cancer treatment. Reports in this field reflect the therapeutic potential of necroptotic cell death induced by nanomaterials in cancer. Also, autophagic cell death induced by nanomaterials alone and as a part of chemo-, radio- and photothermal therapy holds great promise as anticancer therapeutic option. Besides, ferroptosis induction by iron-based nanomaterials in drug delivery, immunotherapy, hyperthermia and imaging systems shows promising results in malignancies. Hence, this review is devoted to the latest efforts and the challenges in this field of research and its clinical merits.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2020 Elsevier